stem cell therapy is for real and it could soon to …...2013/11/18 · problems, renal failure,...

11/18/13 LIFS

lifsreport.com/index.html 1/11

Stem Cell Therapy Is For Real And ItCould Soon To Be Readily Available!

Q: What if heart attack survivors could grow new heart muscle?

Q: What if cancer patients didn’t need chemo or radiation?

Q: What if you could grow new kneecartilage instead of having a total kneereplacement?

Q: What if stroke victims could growreplacement brain cells?

Q: What if failing kidneys no longerrequired dialysis?

Q: What if this one health care company, Life Stem Genetics (LIFS)establishes itself now as the leader in this amazing biotechrevolution?

A: Buy shares of LIFS now, while it’s stillunder $2 and you could turn $10,000into $40,000 in the next 6-9 months!

Fellow Investor:

Life Stem Genetics (LIFS) is a new breed of health care company that’s focused on healingwith a patient’s own “Adult Stem Cells”. The company’s goal is to establish state-of-the-artstem cell clinics all across America and throughout the world, including Asia and the Middle

East, in order to make the miracle of stem therapy available to the millions who could benefitfrom it.

The stem cell market is projected to be worth $75 billion next year!

11/18/13 LIFS


And it appears to me as if Life Stem Genetics is alone in its quest to make revolutionary stemcell therapies available throughout the entire world.

The company’s mission is to create a solid comprehensive approach to the treatment andmaintenance of diseases and to break free from the medical insurance world by tapping intoan affordable private- pay sector delivering exceptional health care free from the medicalinsurance maze.

It Works!And the whole world now has access to it.

For years, the world’s leading medical researchers have known that stem cells have thepotential to successfully treat a variety of ailments, but until recently, those therapies weremostly limited to research hospitals and university medical laboratories.

At Harvard University, regenerative biologist, Dr. Douglas Melton, co-founded theHarvard Stem Cell Institute, known for its world leadership in the stem cell field.

The strong financial backing of industry titans, Bill and Melinda Gates, the founders ofMicrosoft, has provided crucial monetary fuel to help make stem cell therapy a reality.

The Bill and Melinda Gates Foundation is working to speed the use of new stem celltechnologies. Dr. Orin Levine, formerly of Johns Hopkins, is the foundation’s directorof stem cell delivery.

Recent Nobel Prize Laureates, Sir John Bertrand Gurdon and Shinya Yamanaka,are unifying the academic power bases of Europe and Asia in accord with America’sdrive for globalizing Adult Stem Cell therapies. From Cambridge to Kyoto,respectively, Gurdon and Yamanaka are making great strides in Adult Stem Cellscience in unanimity with our National Institute of Health’s Center for RegenerativeMedicine.

Now, Life Stem Genetics Is MakingStem Cell Therapy A Reality!

Life Stem Genetics now has some 60 Affiliate Clinics where it offers proprietary, cutting-edgeand painless adult stem cell therapies to treat many different illnesses:

For orthopedic injuries, regeneratingand repairing tissue,Neurological disorders, such asAlzheimer's, Parkinson's, Stroke,

Autism, Bi-Polar disorder, Braindamage and tumors,Cardiology, heart disease,Cancer,Dermatology,Plastic Surgery, for the regenerationof capillaries and collagen,

11/18/13 LIFS


*Because the projected return oninvestment of the global stem cell

industry is already in the $Billions, I'llwait to put a specific price target onLife Stem Genetics (LIFS) so I don't

have to keep raising it. Now is the timeto make your initial buy on LIFS. Ourinitial valuation of Life Stem's future

market share is well above the currentnear $1 price level and increasing.

of capillaries and collagen,Age Management,Arthritis,Diabetes,COPD, lung conditions,MS,Urology, including impotence,\Baldness, Podiatry, andVeterinaryapplications for pets, andthoroughbred race horses.

Stem cells have now been proven to successfullytreat HIV and they will no doubt continue to breakthrough other health barriers as research continues.

The human body has an absolutely astonishingability to repair itself, far greater than anypharmaceutical or manufactured treatment ever devised by man. So it’s no wonder that theproverbial fountain of youth is found in our own stem cells, which, by the way are now availablein near limitless quantities.

Already, the proprietary stem cell therapies developed by Life Stem Genetics havedemonstrated some of the best results in the industry, helping to repair or re-programdamaged or diseased tissues and organs.

Already The LeaderIn Stem Cell

Therapy!LIFS highly trained Cell Specialists,associated with Life Stem, haveperformed 1,000s of treatments involvingadult stem cells on patients that includesome of the top names in PGA golf, NFLfootball, NBA basketball, and Major LeagueBaseball.

Life Stem Genetics, Inc. now offers itsproprietary treatments through a series ofaffiliate doctors, and medical clinics, with60 clinics so far. And the number of clinics could grow rapidly as more-knowledgeable healthcare consumers continue to look beyond big pharma and Obamacare for answers.

Consider the facts that...

11/18/13 LIFS


This Stock Has “Takeover” Written All Over It!The pharmaceutical giants are already late to this stem cell party!

Once threatened by the anti-drug promise of stem cell therapy, big-pharma now has no choicebut to jump on the band wagon.

But they’re already too far behind, and stakes are too high to reinvent the wheel. They can’tpossibly hope to overcome the current technology lead maintained by innovators like Life StemGenetics (LIFS).

It makes sense for one of the majors to simply open its acquisition checkbook rather than tryand play catch up!

How much might LIFS fetch?

My best forecast calls for $9.09 a share for a stock at the low end… though the biotech spaceis famous for $20+ buyouts… that’s why hurrying could be your best move ever while , LIFStrades at under $2.

Because, who knows what could happen down the road a bit.

If, say Merck and Johnson & Johnson, were to go at it in an all-out bidding war over Life Stem’sproprietary stem cell therapies, you might even see a hammer price way above $9.09.

And to put that into perspective for you, LIFS shares likely still trade under $2 today...

You Could Turn $10,000Into As Much As $45,450!

11/18/13 LIFS


The Science Behind LIFS’s Stem Cell Therapy. (Why buying LIFS stock now is a solid investment)

Because I’m suggesting you may want to move some of your hard-earned money into LIFS, Ibelieve I owe you an explanation of some of the basics of how and why it all works. I’ll try andkeep it as simple as possible, but I do hope you’ll try and stay with me. After all, this is amazingand cutting edge science:

What is a stem cell?

A stem cell is a cell that has the potential to replicate endlessly and to morph into a differenttype of cell. Stem cells have the ability to change into various kinds of tissues based on theirenvironment.

There are many different types of stem cells.

Embryonic (or fetal) stem cells are taken from unborn or unwanted embryos, and there issubstantial political and moral controversy surrounding their use.

Life Stem does not use embryonic stem cells.

Another kind is known as "adult” stem cells. Theywere first discovered in the bone marrow. But onlya small percentage of bone marrow stem cellshave the ability to generate all the different types oftissues.

However, Life Stem Genetics says it haspioneered the use of another type of stem cell thatcan be taken from body fat (or adipose tissue). It isoverloaded with the exactly the most desirable kindof stem cells. Estimates put fat-derived stem cellsto be at least 50% more numerous than from bone

marrow.

What are Adult Stem Cells?

Adult Stem Cells have the ability to replace dying cells and regenerate damaged tissue. Thesespecial cells seek out areas of injury, disease and damage where they are capable ofrejuvenating healthy cells and enhancing a patient's natural healing process.

11/18/13 LIFS


What’s actually involved with one of these therapies?

Before you consider a move into Life Stem, you need to know how easy and painless this is forthe patient.

First, fat is drawn out with a syringe, similar to a micro lipo suction, using a local anesthesia.

The stem cells are separated from the adipose tissue, using a centrifuge. Then Life Stem usesits proprietary protocol to activate the stem cells, achieving the highest stem cell counts in theindustry.

The activated stem cells are then re-introduced into the patient using an IV drip, or in somecases, direct injection. Patients are on their way in about 4 hours, with minimal discomfort.

How Do Life Stem’s Adult Stem Cell Therapies Actually Heal?

The scientific community now recognizes that adult stem cells have the ability to stay dormant(inactive) in the body for years until some type of injury or disease turns them on. Receptors on

the stem cells allow them to migrate to areas that need healing and effect change in that area.Scientists are still unsure if stem cells transform themselves into the specific tissue needed forrepair or if they somehow communicate with existing tissues to initiate healing.

Adult stem cells appear to be particularly effective at repairing cartilage in degenerated jointsand healing damaged eye tissue.

LIFS says its highly trained cell technicians at Life Stem clinics are able to obtain high numbersof adult stem cells from a person's own fat. Stem cell counts vary from patient to patient, butthe company reports always having had a count over 10 million and average counts are wellover 100 million stem cells. This is many times more than could ever be obtained through bonemarrow extraction (even after culture).

Life Stem Genetics has been at the cutting edge of research to discover the enormous healingpotential within these adult stem cells. And, adult stem cells are now being used for a variety ofmedical treatments to repair and regenerate acute and chronically damaged tissues. Andhere’s the thing...

These Therapies Often WorkWhen All Else Has Failed!

If you’re a cancer patient, that could be life-altering news!

11/18/13 LIFS


If you’re an opportunistic investor, searching for the next really big thing – like the birth of themicrochip era – this is also really good news. Because...

Just as the microchip has changed the world inways we could not have imagined, an even moreearth-shaking revolution could now be upon us!

Because, the advent of stem-cell therapy has thepotential to shake the very foundation of the

way we approach disease and aging.

This is not balderdash… not some microcap marketing.

Because, established medical clinics across the globe now use stem cell in therapy to treat avariety of chronic degenerative conditions. These include severe neurologic diseases, eyeproblems, renal failure, erectile dysfunction, degenerative orthopedic problems, and evencardiac and pulmonary diseases.

Keep in mind that the “self-harvesting” of your own Adult Stem Cells (ASC’s) for treating YOUis actually nothing new. It’s been around for decades with roughly 1 million patients in the U.S.alone being successfully treated via ASC’s since the mid-1980’s.

WHAT IS NEW is the “methodology” by which Life Stem is harvesting adult stem cells andthen re-injecting them into the patient – either intravenously or via direct injection into afflictedareas.

Which is why Life Stem Genetics (LIFS) is my #1 pick for potentially expansive shareholdergains as the company begins setting up ASC clinics all over the world utilizing its innovativeAdult Stem Cell Self-Harvesting approach. Best of all, since the stem cells being used are yourown, there’s zero risk of your body rejecting the treatment! The same cannot be said forembryonic stem cell procedures.

11/18/13 LIFS


Opportunity: One Major Press Release Could

Send LIFS Up…Up…Up!

11/18/13 LIFS


*Because the projected return oninvestment of the global stem cell

industry is already in the $Billions, I'llwait to put a specific price target onLife Stem Genetics (LIFS) so I don't

have to keep raising it. Now is the timeto make your initial buy on LIFS. Ourinitial valuation of Life Stem's future

market share is well above the currentnear $1 price level and increasing.

I think of all that Life Stem Genetics (LIFS) hasalready accomplished – and then I remember thestock is trading under $2 per share. It’s exciting tome that one of humanity’s greatest opportunities canalso be one of the most profitable investments —EVER. I don’t have to tell you what success meansin the field of Adult Stem Cell therapies. The potentialto successfully treat and potentially cure some of themost debilitating diseases known to man cantranslate to life-changing gains for well-timed,properly positioned investors.

Life Stem Has The Potential For YourEarlier Retirement.

I believe that if you let this opportunity pass you by,you’ll regret it for years to come. That’s something Ihope you’ll instinctively want to avoid.

Rarely am I this enthusiastic about a microcap stock

– but LIFS has huge upside potential written all overit. Just as Medbox did this time a year ago.

A microcap on the OTCBB, it soared from $3.45 tomore than $214 in just days before settling down totrade above $20.

And yes, I’m cherry picking Medbox. But, It is just another reminder of the sudden fortunes thatcan be built with microcap stocks.

Because it could define a new market – potentially claiming the market for itself – Life Stemdisplays strong signs of becoming a massive stock market success story.

I recommend you move on LIFS now. Buy only what you’re comfortable with and then watch it.I’m confident you’ll soon be adding to your position once you see the immense profit potentialin-play.

The Next Move Is Yours...Timing is everything in the stock market. Wall Street operates on a “herd” mentality. Once theysee something big, they all rush in at the same time. Yet, I’ve always said that the largestshareholder gains go to those with the foresight to buy early BEFORE the secret’s out – whenthe share-price is still at bargain basement prices. That time is NOW.

Andy Carpenter

Co-Editor, The Wall Street Revelator

P.S. Act now. . .a big-pharma take over could send this stock soaring at any moment.

Get in now while you can still get LIFS under $2 a share.

P.P.S. To discover the hidden power of under-valued stocks be sure to sign up for a

subscription to

The Wall Street Revelator

11/18/13 LIFS


The Wall Street Revelator

It’s ONLY $99 a year… and your subscription toThe Wall Street Revelator grants you immediateaccess to two decades of “in-the-trenches” investingexperience … responsible, sane commentary thatis rare to find today when it comes to financeand investing… real-world insights aimed atguiding you to superior results … the kind that beat anything you’ve experienced before!

Meet The Stock Market’s Power Couple

She’s world-renowned… a former editor of The Fleet Street Letter Editor, Oxford Club WealthAdvisory Panel member and founder of The Rising Tide Value Letter… a legend for high-

return, risk-adverse stock market value investing…

He’s a Harvard-educated globetrotter… founder of The China Club and Asia Business &Investing… a legend for obscene profits from across the globe.

They are Andy and Lynn Carpenter… the stock market’s power couple… founders and editorsof The Wall Street Revelator.

SUBSCRIBING TODAY IS EASY!

Go to www.WallStreetRevelator.com

WALL STREET JOURNAL –Andrew Carpenter has an uncanny knack fordiscovering companies “that fly below the radar screens of most Wall Streetanalysts… He digs up information on companies Wall Street can’t be bothered with.”

JOHN MAULDIN – I particularly like Lynn Carpenter… who is a contrarian valueinvestor” – from page 384, of his international bestseller, Bullseye Investing. And, “Ano-nonsense value oriented stock picker with a solid track record… I have alwaysbeen a big fan.”

USA TODAY – Andrew Carpenter, “Predicted one stock winner after another.”

BILL BONNER – “Has Warren Buffett been reading my old friend, LynnCarpenter’s reports? It sure looks that way… A value investor with her ownproprietary system, Lynn’s been beating Warren Buffett to the goodies.”

CANADIAN MINING NEWS – Anyone can recommend stocks, but [Carpenter]recommends outstanding companies — ones specifically chosen to help

http://www.wallstreetrevelator.com/

11/18/13 LIFS


recommends outstanding companies — ones specifically chosen to helpsubscribers steadily increase their wealth in all markets. No fads, no hype…unbiased research and common sense, and all written clearly and enjoyably forsmart investors who like to make their own decisions.

INVESTMENT U – Those who attended the Oxford Club’s Investment Universityconference in March cashed in on a 129% option winner just 10 days after Lynngave it to them. That’s nothing new for Lynn, whose world-renowned servicedelivered 51 winners that ranged between 57% and 299% in the last two yearsalone.

DAILY RECKONING – “YOU COULD'VE MADE 91% IN ONE DAY! or as one fellowinvestor put it: ‘I wanted to thank you for [your] efforts…in the last couple of weeksthe information [you supplied] has produced a realized total of $23,210.’”

DAVE NORMAN – “I have done so well with your newsletters in the past, please letme know when you get the new newsletter ready.”

MARION HOTCHKISS – Thank you, Lynn, for providing confidence I can alwaysuse. I enjoyed your "journey" through the how-to-understand-the stock-market maze.

NED DEMERS – With you I feel like I am getting the right investment scoop and nota lot of useless political poop.

GEORGE STEWART – Thanks for the nice piece, it's good to read somestraightforward talk for a change! Thanks!

IMPORTANT NOTICE AND DISCLAIMER: Andrew Carpenter’s Wall Street Revelator Advisory (WSR), does not purport to provide an analysis of any company's

financial position, operations or prospects and this is not to be construed as a recommendation by WSR or an offer or solicitation to buy or sell any security. Eclipse

Media Group. has used outside research and writers using public information to create the advertisement coming from WSR about Life stem Genetics, Inc. Although

the information contained in this advertisement is believed to be reliable, WSR and Eclipse Media Group, make no warranties as to the accuracy of any of the

content herein and accept no liability for how readers may choose to utilize the content. The opinions expressed in this advertisement and special report are solely

those of WSR, unless otherwise referenced. Readers should perform their own due diligence, including consulting with a licensed, qualified investment

professional or analyst. Further, readers are strongly urged to independently verify all statements made in this Special Report and perform extensive due diligence

on this or any other mentioned company. Eclipse Meda Group. and WSR or affiliates are not offering securities for sale. An offer to buy or sell can be made only with

accompanying disclosure documents and only in the states and provinces for which they are approved. Many states have established rules requiring the approval

of a security by a state security administrator. Check with http://www.nasaa.org or call your state security administrator to determine whether a particular security is

licensed for sale in your state. Many companies have information filed with state securities regulators and many will supply investors with additional information on

request. Eclipse Media Group. has paid a total production budget of $1,789,000 for this advertising efforts. Andrew Carpenter’s Wall Street Revelator Advisor is

paid seven thousand five hundred dollars as an editorial fee from Eclipse Media Group.. *More information can be received from Life Stem Genetics investor

relations firm, or at Life Stem Genetics website lifestemgenetics.com. Further specific information, filings and disclosures as well as general investor information

about publicly traded companies like Life Stem Genetics., advice to investors and other investor resources are available at the Securities and Exchange

Commission website www.sec.gov and www.nasd.com. Any investment should be made only after consulting with a qualified investment advisor and after reviewing

the publicly available financial statements of and other information about the company and verifying that the investment is appropriate and suitable. Investing in

securities is highly speculative and carries a great deal of risk especially as to new companies with limited operations and no history of earnings. The information

contained herein contains forward-looking information within the meaning of section 27a of the Securities Act of 1993, as amended, and section 21e of the

Securities Exchange Act of 1934, as amended, including statements regarding expected growth of the featured company. In accordance with the safe harbor

provisions of the Private Securities Litigation Reform Act, Life Stem genetics. notes that statements contained herein that look forward in time, which include

everything other than historical information, involve risks and uncertainties that may affect the Company's actual results of operations. Factors that could cause

actual results to differ include the size and growth of the market, the Company's ability to fund its capital requirements in the near term and in the long term; pricing

pressures, technology issues, etc. Product names, logos, brands, and other trademarks featured or referred to within this report are the property of their respective

trademark holders. These trademark holders are not affiliated with WSR.

stem cell therapy is for real and it could soon to …...2013/11/18 · problems, renal failure,...

Documents